The strategic partnership will establish a joint solution for the efficient creation of buffers created from concentrates delivered directly to manufacturing facilities, increasing productivity and ...

Managing buffers in bioprocessing remains a largely manual process, requiring space and resources and often creating bottlenecks that increase costs and decrease efficiency. Researchers from many of ...

Nucleus Biologics launched the Krakatoa ® K500, which the company says is the first bioreactor-scale, pod-based media and buffer manufacturing system designed to deliver sterile solutions on demand ...

Discover valuable insights for transforming your biopharmaceutical production with our comprehensive resource. We take a deep dive into the latest industry trend of outsourcing buffer and process ...

NB-Lux™ AI connects formulation through GMP manufacturing in a single AI-enabled ecosystem, accelerating timelines and improving transparency from R&D through Excipient GMP. Built off NB-Lux™, the ...

We listened to our customers’ frustrations with the complex process of centralized GMP liquid media manufacturing. With the Krakatoa® K500, we begin a journey to co-locate both media and buffer ...

PORT WASHINGTON, N.Y.--(BUSINESS WIRE)--Aceto, a leading global provider of specialty materials for life sciences and advanced technology end markets, announced today its acquisition of A&C Bio Buffer ...

The "Buffer Preparation Market Industry Trends and Global Forecasts to 2035: Distribution by Scale of Operation, Type of System Component, Type of Buffer Formulation, Type of Molecule, Type of ...

Framing media/buffer risk around lead time, consistency, and expiry aligns raw-material controls with clinical urgency and unpredictable consumption patterns. On-site manufacture can reduce ...

Discover how alternative buffer management strategies can reduce footprint, cut costs, and streamline downstream bioprocessing. Explore practical approaches, like buffer concentrates and stock ...